Logo image of ACHC

ACADIA HEALTHCARE CO INC (ACHC) Stock Fundamental Analysis

NASDAQ:ACHC - Nasdaq - US00404A1097 - Common Stock - Currency: USD

45.06  +0.26 (+0.58%)

After market: 45.06 0 (0%)

Fundamental Rating

5

ACHC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 109 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of ACHC while its profitability can be described as average. ACHC is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

ACHC had positive earnings in the past year.
In the past year ACHC had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ACHC reported negative net income in multiple years.
Each year in the past 5 years ACHC had a positive operating cash flow.
ACHC Yearly Net Income VS EBIT VS OCF VS FCFACHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.78%, ACHC is in the better half of the industry, outperforming 78.70% of the companies in the same industry.
The Return On Equity of ACHC (9.26%) is better than 76.85% of its industry peers.
ACHC has a Return On Invested Capital of 7.74%. This is in the better half of the industry: ACHC outperforms 74.07% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACHC is in line with the industry average of 8.07%.
The 3 year average ROIC (7.51%) for ACHC is below the current ROIC(7.74%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.78%
ROE 9.26%
ROIC 7.74%
ROA(3y)3.02%
ROA(5y)0.06%
ROE(3y)5.5%
ROE(5y)-2.91%
ROIC(3y)7.51%
ROIC(5y)6.2%
ACHC Yearly ROA, ROE, ROICACHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30

1.3 Margins

ACHC's Profit Margin of 8.99% is amongst the best of the industry. ACHC outperforms 92.59% of its industry peers.
With an excellent Operating Margin value of 17.42%, ACHC belongs to the best of the industry, outperforming 98.15% of the companies in the same industry.
In the last couple of years the Operating Margin of ACHC has grown nicely.
Industry RankSector Rank
OM 17.42%
PM (TTM) 8.99%
GM N/A
OM growth 3Y2.8%
OM growth 5Y1.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACHC Yearly Profit, Operating, Gross MarginsACHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20 -30

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACHC is destroying value.
The number of shares outstanding for ACHC has been increased compared to 1 year ago.
ACHC has more shares outstanding than it did 5 years ago.
ACHC has a better debt/assets ratio than last year.
ACHC Yearly Shares OutstandingACHC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
ACHC Yearly Total Debt VS Total AssetsACHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

ACHC has an Altman-Z score of 1.82. This is not the best score and indicates that ACHC is in the grey zone with still only limited risk for bankruptcy at the moment.
ACHC's Altman-Z score of 1.82 is in line compared to the rest of the industry. ACHC outperforms 47.22% of its industry peers.
ACHC has a Debt/Equity ratio of 0.60. This is a neutral value indicating ACHC is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.60, ACHC is in line with its industry, outperforming 55.56% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Altman-Z 1.82
ROIC/WACC0.97
WACC7.98%
ACHC Yearly LT Debt VS Equity VS FCFACHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

ACHC has a Current Ratio of 1.07. This is a normal value and indicates that ACHC is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.07, ACHC is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
ACHC has a Quick Ratio of 1.06. This is a normal value and indicates that ACHC is financially healthy and should not expect problems in meeting its short term obligations.
ACHC's Quick ratio of 1.06 is on the low side compared to the rest of the industry. ACHC is outperformed by 65.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 1.06
ACHC Yearly Current Assets VS Current LiabilitesACHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

More info and screens

6

3. Growth

3.1 Past

ACHC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.01%.
Measured over the past years, ACHC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.90% on average per year.
The Revenue has grown by 9.13% in the past year. This is quite good.
Measured over the past years, ACHC shows a quite strong growth in Revenue. The Revenue has been growing by 8.99% on average per year.
EPS 1Y (TTM)7.01%
EPS 3Y7.38%
EPS 5Y8.9%
EPS Q2Q%0%
Revenue 1Y (TTM)9.13%
Revenue growth 3Y11.91%
Revenue growth 5Y8.99%
Sales Q2Q%8.7%

3.2 Future

Based on estimates for the next years, ACHC will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.50% on average per year.
Based on estimates for the next years, ACHC will show a quite strong growth in Revenue. The Revenue will grow by 9.66% on average per year.
EPS Next Y0.95%
EPS Next 2Y0.4%
EPS Next 3Y4.62%
EPS Next 5Y8.5%
Revenue Next Year8.45%
Revenue Next 2Y8.74%
Revenue Next 3Y9.03%
Revenue Next 5Y9.66%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ACHC Yearly Revenue VS EstimatesACHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
ACHC Yearly EPS VS EstimatesACHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

ACHC is valuated correctly with a Price/Earnings ratio of 12.84.
ACHC's Price/Earnings ratio is rather cheap when compared to the industry. ACHC is cheaper than 87.96% of the companies in the same industry.
ACHC is valuated cheaply when we compare the Price/Earnings ratio to 28.47, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 13.03, ACHC is valued correctly.
Based on the Price/Forward Earnings ratio, ACHC is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of ACHC to the average of the S&P500 Index (92.74), we can say ACHC is valued rather cheaply.
Industry RankSector Rank
PE 12.84
Fwd PE 13.03
ACHC Price Earnings VS Forward Price EarningsACHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

82.41% of the companies in the same industry are more expensive than ACHC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.68
ACHC Per share dataACHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ACHC does not grow enough to justify the current Price/Earnings ratio.
ACHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)13.54
PEG (5Y)1.44
EPS Next 2Y0.4%
EPS Next 3Y4.62%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACHC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACADIA HEALTHCARE CO INC

NASDAQ:ACHC (2/4/2025, 8:24:56 PM)

After market: 45.06 0 (0%)

45.06

+0.26 (+0.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)02-27 2025-02-27/amc
Inst Owners105.72%
Inst Owner Change0.36%
Ins Owners1%
Ins Owner Change-0.01%
Market Cap4.19B
Analysts83.16
Price Target62.3 (38.26%)
Short Float %6.57%
Short Ratio3.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.59%
Min EPS beat(2)-1.26%
Max EPS beat(2)2.44%
EPS beat(4)3
Avg EPS beat(4)2.12%
Min EPS beat(4)-1.26%
Max EPS beat(4)5.12%
EPS beat(8)6
Avg EPS beat(8)1.16%
EPS beat(12)9
Avg EPS beat(12)9.91%
EPS beat(16)12
Avg EPS beat(16)12.81%
Revenue beat(2)0
Avg Revenue beat(2)-1.46%
Min Revenue beat(2)-2.42%
Max Revenue beat(2)-0.51%
Revenue beat(4)1
Avg Revenue beat(4)-1.55%
Min Revenue beat(4)-3.36%
Max Revenue beat(4)0.09%
Revenue beat(8)4
Avg Revenue beat(8)-0.49%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)5
Avg Revenue beat(16)-4.74%
PT rev (1m)0.68%
PT rev (3m)-28.91%
EPS NQ rev (1m)-0.11%
EPS NQ rev (3m)-16.53%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)-3.32%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-5.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.41%
Valuation
Industry RankSector Rank
PE 12.84
Fwd PE 13.03
P/S 1.34
P/FCF N/A
P/OCF 32.36
P/B 1.38
P/tB 6.04
EV/EBITDA 8.68
EPS(TTM)3.51
EY7.79%
EPS(NY)3.46
Fwd EY7.67%
FCF(TTM)-5.34
FCFYN/A
OCF(TTM)1.39
OCFY3.09%
SpS33.62
BVpS32.64
TBVpS7.47
PEG (NY)13.54
PEG (5Y)1.44
Profitability
Industry RankSector Rank
ROA 4.78%
ROE 9.26%
ROCE 10.34%
ROIC 7.74%
ROICexc 7.86%
ROICexgc 14.33%
OM 17.42%
PM (TTM) 8.99%
GM N/A
FCFM N/A
ROA(3y)3.02%
ROA(5y)0.06%
ROE(3y)5.5%
ROE(5y)-2.91%
ROIC(3y)7.51%
ROIC(5y)6.2%
ROICexc(3y)7.7%
ROICexc(5y)6.4%
ROICexgc(3y)16.2%
ROICexgc(5y)12.86%
ROCE(3y)10.04%
ROCE(5y)8.28%
ROICexcg growth 3Y24.65%
ROICexcg growth 5Y20.82%
ROICexc growth 3Y18.77%
ROICexc growth 5Y16.69%
OM growth 3Y2.8%
OM growth 5Y1.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Debt/EBITDA 2.62
Cap/Depr 430.27%
Cap/Sales 20.04%
Interest Coverage 250
Cash Conversion 18.76%
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 1.06
Altman-Z 1.82
F-Score5
WACC7.98%
ROIC/WACC0.97
Cap/Depr(3y)267.08%
Cap/Depr(5y)260.42%
Cap/Sales(3y)12.13%
Cap/Sales(5y)11.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.01%
EPS 3Y7.38%
EPS 5Y8.9%
EPS Q2Q%0%
EPS Next Y0.95%
EPS Next 2Y0.4%
EPS Next 3Y4.62%
EPS Next 5Y8.5%
Revenue 1Y (TTM)9.13%
Revenue growth 3Y11.91%
Revenue growth 5Y8.99%
Sales Q2Q%8.7%
Revenue Next Year8.45%
Revenue Next 2Y8.74%
Revenue Next 3Y9.03%
Revenue Next 5Y9.66%
EBIT growth 1Y11.17%
EBIT growth 3Y15.03%
EBIT growth 5Y10.64%
EBIT Next Year57.95%
EBIT Next 3Y22.47%
EBIT Next 5YN/A
FCF growth 1Y-830.92%
FCF growth 3Y-52.6%
FCF growth 5Y-6.79%
OCF growth 1Y-64.56%
OCF growth 3Y-7.48%
OCF growth 5Y2.23%